US Patent Issued to Nico Therapeutics on July 28 for "Substituted triazine compound" (Japanese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,241, issued on July 28, was assigned to Nico Therapeutics Inc. (Chicago).

"Substituted triazine compound" was invented by Yusuke Inagaki (Tokyo), Yumi Yamashita (Tokyo), Hiroki Toya (Tokyo), Takuya Washio (Tokyo), Fumie Takahashi (Tokyo), Kengo Saba (Tokyo), Hiroshi Tomiyama (Nagano, Japan), Yoshinori Iwai (Nagano, Japan) and Akihiko Nakamura (Nagano, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide a pharmaceutical composition, particularly a compound suitable for preventing and/or treating an inflammatory disease and/or a neurodegenerative disease. The present inventors accomplished the present ...